Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. clinitrial

CliniTrial

Enhancement of an advanced clinical trial recruitment platform for Europe to ensure maximum intake of eligible consenting patients for participation

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 CliniTrial project word cloud

Explore the words cloud of the CliniTrial project. It provides you a very rough idea of what is the project "CliniTrial" about.

cured    newly    suffer    lack    deciding    advocacy    health    provides    missing    easily    groups    contact    right    germany    viomedo    rolled    pharmaceutical    patients    takes    ready    care    supports    givers    learning    helping    attractive    quality    openness    mainly    eligibility    pilots    managed    therapy    trial    time    turn    confirm    diseases    75    patient    once    markets    six    rollout    unfortunately    search    innovative    clinical    recruit    public    disruptive    validated    doctors    run    acquisition    internet    standard    reached    centricity    solution    platform    hope    disease    market    industry    earlier    therapies    many    milestones    beta    empowers    benefit    choose    business    date    strategy    companies    region    online    complete    recruiting    participate    money    pilot    investigator    trials    centric    version    conducting   

Project "CliniTrial" data sheet

The following table provides information about the project.

Coordinator		 VIOMEDO UG (HAFTUNGSBESCHRANKT) 

Organization address
address: LAUSITZER STRASSE 18
city: BERLIN
postcode: 10999
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Germany [DE]
 Project website http://www.viomedo.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VIOMEDO UG (HAFTUNGSBESCHRANKT) DE (BERLIN) coordinator 50˙000.00

Map

 Project objective

Many patients can’t effectively be treated with the standard of care today. They suffer from their diseases that can’t be managed or cured. Newly developed therapies represent their only hope. Unfortunately, it takes ever more time and money to bring innovative therapies to market. A major challenge in clinical development is finding the right patients to participate in clinical trials. The problem is that patients lack access to trials. The online platform viomedo supports patients with finding the right clinical trial for them, while helping the organizations that run trials, such as pharmaceutical companies, recruit patients more efficiently. The disruptive solution provides access to over 2.000 up-to-date clinical trials that are recruiting patients in Germany. Patients, care givers or doctors can easily search for a trial by disease, confirm their eligibility and contact the investigator. Patients want to be increasingly involved in deciding which therapy to choose. 75% of them are interested in learning about clinical trial opportunities. Most turn mainly to the internet for health-related information. However, a patient-centric online platform for clinical trials is missing. Viomedo empowers patients by providing this platform. Important milestones – such as the development of a public beta version of the platform, collaboration with leading patient advocacy groups, acquisition of six large pilots with pharmaceutical companies – have been reached. The goal of phase 1 is to complete the pilot projects and develop an EU-wide rollout strategy. After the business case is ready and validated, viomedo will be rolled out to major European markets in phase 2. Once viomedo is rolled out to all European patients, it will help more patients benefit from the research earlier. It will also make the EU a more attractive region for conducting research. It will help bring patient centricity and openness into the industry, raising the quality of clinical research conducted.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CLINITRIAL" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CLINITRIAL" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More